The State of AMR: Gram-Negative/Positive Resistance and Pipeline Challenges
From Editors in Conversation · · 39 min
This plays from the publisher's own server. We do not host a copy.
Description
Multidrug-resistant infections remain one of the most urgent public health challenges worldwide, with some infections approaching the limits of available treatment options. CDC just released their latest report that indicates that AMR is likely to kill more than 50,000 people a year in the US alone.
Dr. William Miller's broad expertise in AMR makes him the perfect fit as an editor of the Antimicrobial Agents and Chemotherapy Journal and will reflect in this episode on the major challenges of the future of AMR in a complex and rapidly changing field.
Topics discussed: - The current state of AMR
- The major challenges both in Gram-positive and Gram-negative resistance
- The antibiotic pipeline and promises for the future
- How the field will move in the next 10 years.
Guest: - William R. Miller, M.D., Professor of Medicine, Houston Methodist Hospital
Links: This episode is brought to you by the Antimicrobial Agents and Chemotherapy Journal.
Visit asm.org/ (https://aac.asm.org)aa (https://aac.asm.org)c to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/joinasm to sign up.